Nirvana Life Sciences Inc Financial Overview
Nirvana Life Sciences Inc's market cap is currently C$1.37M. The company's EPS TTM is C$; its P/E ratio is ―; Nirvana Life Sciences Inc is scheduled to report earnings on September 8, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.